Jon R Christiansen1, Richard Massey2, Håvard Dalen3, Adriani Kanellopoulos4, Hanne Hamre5, Ellen Ruud4, Cecilie E Kiserud5, Sophie D Fosså6, Svend Aakhus7. 1. Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway Department of Medicine, Innlandet Hospital Trust, Elverum, Norway jorch@online.no. 2. Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. 3. Department of Medicine, Levanger Hospital, Nord-Trøndelag Health Trust, Levanger, Norway Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway. 4. Department of Paediatric Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway. 5. National Advisory Unit for Late Effects after Cancer Treatment, Oslo University Hospital, Radiumhospitalet, Oslo, Norway. 6. National Advisory Unit for Late Effects after Cancer Treatment, Oslo University Hospital, Radiumhospitalet, Oslo, Norway Cancer Registry of Norway, Oslo, Norway. 7. Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway.
Abstract
AIMS: Little is known about right ventricular (RV) function in survivors of childhood cancer, although both anthracyclines and radiotherapy represent potentially cardiotoxic treatment. We hypothesized that adult survivors of childhood malignant lymphoma or acute lymphoblastic leukaemia would have impaired RV function. METHODS AND RESULTS: We examined RV dimensions and function by echocardiography in 246 survivors, mean 21.7 years after diagnosis, and in 211 matched controls. Of the survivors, 84% had been exposed to anthracyclines, mediastinal radiotherapy, or both. Compared with controls, all mean measures of RV function were lower in the survivor group: fractional area change (44.5 vs. 48.6%, P < 0.001), tricuspid annular plane systolic excursion (2.24 vs. 2.49 cm, P < 0.001), peak systolic tricuspid annular velocity (12.1 vs. 13.0 cm/s, P < 0.001), and free wall strain (-26.5 vs. -28.4%, P < 0.001). In contrast, there were little differences in RV diastolic dimensions. Lower measures of RV function were found in all survivor subgroups having received cardiotoxic treatment, but not in the 16% of survivors unexposed to anthracyclines or mediastinal radiotherapy. Signs of RV systolic dysfunction were found in 30% of the survivors, and more than 3 times more often in survivors with left ventricular dysfunction. CONCLUSION: Long-term survivors of childhood lymphoma or acute lymphoblastic leukaemia frequently have impaired RV function compared with controls. As this is associated with increased risk of heart failure and death in many other conditions, we recommend increased attention to RV function in childhood survivors. Whether RV dysfunction impairs prognosis in this patient group should be examined in longitudinal studies. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Little is known about right ventricular (RV) function in survivors of childhood cancer, although both anthracyclines and radiotherapy represent potentially cardiotoxic treatment. We hypothesized that adult survivors of childhood malignant lymphoma or acute lymphoblastic leukaemia would have impaired RV function. METHODS AND RESULTS: We examined RV dimensions and function by echocardiography in 246 survivors, mean 21.7 years after diagnosis, and in 211 matched controls. Of the survivors, 84% had been exposed to anthracyclines, mediastinal radiotherapy, or both. Compared with controls, all mean measures of RV function were lower in the survivor group: fractional area change (44.5 vs. 48.6%, P < 0.001), tricuspid annular plane systolic excursion (2.24 vs. 2.49 cm, P < 0.001), peak systolic tricuspid annular velocity (12.1 vs. 13.0 cm/s, P < 0.001), and free wall strain (-26.5 vs. -28.4%, P < 0.001). In contrast, there were little differences in RV diastolic dimensions. Lower measures of RV function were found in all survivor subgroups having received cardiotoxic treatment, but not in the 16% of survivors unexposed to anthracyclines or mediastinal radiotherapy. Signs of RV systolic dysfunction were found in 30% of the survivors, and more than 3 times more often in survivors with left ventricular dysfunction. CONCLUSION: Long-term survivors of childhood lymphoma or acute lymphoblastic leukaemia frequently have impaired RV function compared with controls. As this is associated with increased risk of heart failure and death in many other conditions, we recommend increased attention to RV function in childhood survivors. Whether RV dysfunction impairs prognosis in this patient group should be examined in longitudinal studies. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Marjan Boerma; Catherine M Davis; Isabel L Jackson; Dörthe Schaue; Jacqueline P Williams Journal: Int J Radiat Biol Date: 2021-07-01 Impact factor: 2.694
Authors: Richard John Massey; Phoi Phoi Diep; Marta Maria Burman; Anette Borger Kvaslerud; Lorentz Brinch; Svend Aakhus; Lars Gullestad; Ellen Ruud; Jan Otto Beitnes Journal: Open Heart Date: 2021-12
Authors: Vladimír Kincl; Roman Panovský; Tomáš Kepák; Viera Bajčiová; Veronika Bednárová; Lukáš Opatřil; Jan Máchal Journal: Cancer Med Date: 2022-02-15 Impact factor: 4.711